Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2011-08, Vol.55 (8), p.3703-3708
Hauptverfasser:	PATEL, Samir N, MCGEER, Allison, MELANO, Roberto, TYRRELL, Gregory J, GREEN, Karen, PILLAI, Dylan R, LOW, Donald E
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents Anti-Bacterial Agents - pharmacology Antibiotics. Antiinfectious agents. Antiparasitic agents Aza Compounds - pharmacology Bacterial diseases Binding Sites Biological and medical sciences Canada Ciprofloxacin - pharmacology DNA Gyrase - drug effects DNA Gyrase - genetics DNA Topoisomerase IV - drug effects DNA Topoisomerase IV - genetics Drug Resistance, Bacterial Drug Resistance, Bacterial - genetics Epidemiology and Surveillance Fluoroquinolones - pharmacology Human bacterial diseases Humans Infectious diseases Levofloxacin Medical sciences Microbial Sensitivity Tests Ofloxacin - pharmacology Pharmacology. Drug treatments Pneumococcal Infections - drug therapy Pneumococcal Infections - epidemiology Pneumococcal Infections - genetics Quinolines - pharmacology Staphylococcal infections, streptococcal infections, pneumococcal infections Streptococcus pneumoniae Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!